The seven A/B Medicare Administrative Contractors (MACs) are withdrawing the local coverage determinations (LCDs) for skin substitute grafts/cellular and tissue-based products for the treatment of dia ...
Dec 26, 2025–Kerecis, the company pioneering the use of sustainably sourced fish skin in cellular therapy and tissue ...
Celularity Inc. (Nasdaq: CELU) (“Celularity”), a regenerative and cellular medicine company addressing age-related and degenerative diseases, today released comments by Robert J. Hariri, M.D., Ph.D., ...
MTF Biologics' AmnioBand® Membrane and AlloPatch® Pliable are among the 18 tissues that will be covered under the newly ...
Organogenesis (ORGO) commends the decision by the U.S. Centers for Medicare & Medicaid Services on local coverage determination based on peer-reviewed and evidence-based data of clinical efficacy. The ...
The U.S. Centers for Medicare & Medicaid Services decided to peel back a series of local coverage determinations for skin substitute grafts that provoked a vigorous response from stakeholders.
Please provide your email address to receive an email when new articles are posted on . Five Medicare Administrative Contractors have withdrawn their final local coverage determinations for ...
The Centers for Medicare & Medicaid Services (CMS) uses coverage determinations to decide how Medicare should cover treatments, services, and items. These rules usually apply nationwide. The CMS ...
Membrane and AlloPatch (R) Pliable are among the 18 tissues that will be covered under the newly updated Medicare Local Coverage Determinations (LCDs) for skin substitute grafts/cellular and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback